Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients

AIM: Soluble suppression of tumorigenicity‐2 (sST2) is a strong prognostic biomarker in heart failure. The emerging understanding of circadian biology in cardiovascular disease may lead to novel applications in prognosis and diagnosis and may provide insight into mechanistic aspects of the disease–b...

Descripción completa

Detalles Bibliográficos
Autores principales: Crnko, Sandra, Printezi, Markella I., Jansen, Tijn P.J., Leiteris, Laurynas, van der Meer, Manon G., Schutte, Hilde, van Faassen, Martijn, du Pré, Bastiaan C., de Jonge, Nicolaas, Asselbergs, Folkert W., Gaillard, Carlo A.J.M., Kemperman, Hans, Doevendans, Pieter A., Sluijter, Joost P.G., van Laake, Linda W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261542/
https://www.ncbi.nlm.nih.gov/pubmed/32233077
http://dx.doi.org/10.1002/ehf2.12673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261542/
https://www.ncbi.nlm.nih.gov/pubmed/32233077
http://dx.doi.org/10.1002/ehf2.12673

Ejemplares similares